Neuronetics Announces the Appointment of Keith J. Sullivan as President and Chief Executive Officer
Keith’s track record includes successfully growing multiple MedTech businesses, driving innovation and impressive market development
We believe that Keith’s experience in commercializing products that involve both capital equipment and recurring revenue streams is an excellent fit with Neuronetics, and I am confident his public company experience and leadership skills further position Neuronetics extremely well for strong execution
Mr. Sullivan brings over three decades of medical device industry experience to the company
Mr. Sullivan, who has more than 30 years of senior sales leadership experience in the medical device industry
Mr. Sullivan received a Bachelor of Business Administration from the College of William and Mary and is a clinical professor in the Mason School of Business at William and Mary.
globenewswire.com/news-release/2020/07/14/2062184/0/en/Neuronetics-Announces-the-Appointment-of-Keith-J-Sullivan-as-President-and-Chief-Executive-Officer.html
Keith’s track record includes successfully growing multiple MedTech businesses, driving innovation and impressive market development
We believe that Keith’s experience in commercializing products that involve both capital equipment and recurring revenue streams is an excellent fit with Neuronetics, and I am confident his public company experience and leadership skills further position Neuronetics extremely well for strong execution
Mr. Sullivan brings over three decades of medical device industry experience to the company
Mr. Sullivan, who has more than 30 years of senior sales leadership experience in the medical device industry
Mr. Sullivan received a Bachelor of Business Administration from the College of William and Mary and is a clinical professor in the Mason School of Business at William and Mary.
globenewswire.com/news-release/2020/07/14/2062184/0/en/Neuronetics-Announces-the-Appointment-of-Keith-J-Sullivan-as-President-and-Chief-Executive-Officer.html
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。